Conmed stock rocketed closer to breakout territory Monday on reports the medtech company is exploring a possible sale.
Conmed Surges Within Striking Distance Of A Breakout On Buyout Rumors
Licensing
Conmed (CNMD) stock rocketed closer to breakout territory Monday on reports the medtech company is exploring a possible sale. Needham analyst Mike Matson said a sale makes sense "given CNMD's mid-single digit growth, strong recurring revenue composition, and depressed valuation." Conmed makes surgical devices and equipment, and patient monitoring systems. Matson expects a 30% to 50% premium to the stock's…
CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026
CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting
CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer
OneMedNet shares surged 33% after hours after announcing an $11.5 million agreement to supply its AI-ready healthcare data…
Danaher shares fell on the news that it was acquiring medtech player Masimo.
Chart analyst Frank Cappelleri goes through the charts that make this stock an attractive play.
